Postanesthetic complications in patients undergoing open hepatectomy
Conditions
Brief summary
Composite endpoint defined as the occurrence of a postoperative opioid-related adverse event within the first 48 hours after extubation, like : postoperative nausea and vomiting, postoperative hypoxemia (SpO₂ < 95% requiring oxygen supplementation), or postoperative ileus (intolerance to an oral diet, e.g., soft food or light meal), assessed blinded to the randomization group.
Detailed description
Occurrence of a postoperative opioid-related nausea and vomiting within the first 48 hours after extubation ; the need for anti-emetic medication will also be recorded, Occurrence of a postoperative opioid-related hypoxemia within the first 48 hours after extubation ; the duration of oxygen treatment will also be recorded, Occurrence of a postoperative opioid-related ileus within the first 48 hours after extubation, Occurrence of a postoperative opioid-related absence of flatus or stools, Postoperative pain (numeric rating scale) after extubation at rest and during movement: every 10 minutes in PACU (Post-Anesthesia Care Unit) and every 6 hours until 48 hours after surgery, Opioid consumption (mg) during the 48 hours following extubation, Time between extubation (H0) and an Aldrete score ≥ 9, Rate of unscheduled admission in intensive care unit, Hospital length of stay (max 28 days) defined as the number of days after extubation (H0) before first hospital discharge, Pneumonia episodes of newly confirmed pneumonia according to the modified CDC criteria within 7 days after surgery or until patient’s discharge from the hospital (max 28 days), Acute kidney insufficiency defined with KDIGO ≥ 2 within 7 days after surgery or until patient’s discharge from the hospital (max 28 days), Need for reintervention because of surgical complication within 7 days after surgery or until patient’s discharge from the hospital (max 28 days), New onset of postoperative atrial fibrillation within 7 days after surgery or until patient’s discharge from the hospital (max 28 days), Quality of recovery measured with the QoR40 score between 24 and 48 hours after extubation, Adverse effects of IV experimental treatment, Ancillary pharmacological study in 20 patients included in the coordinating centre: plasma lidocaine concentration
Interventions
Sponsors
Eligibility
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Composite endpoint defined as the occurrence of a postoperative opioid-related adverse event within the first 48 hours after extubation, like : postoperative nausea and vomiting, postoperative hypoxemia (SpO₂ < 95% requiring oxygen supplementation), or postoperative ileus (intolerance to an oral diet, e.g., soft food or light meal), assessed blinded to the randomization group. | — |
Secondary
| Measure | Time frame |
|---|---|
| Occurrence of a postoperative opioid-related nausea and vomiting within the first 48 hours after extubation ; the need for anti-emetic medication will also be recorded, Occurrence of a postoperative opioid-related hypoxemia within the first 48 hours after extubation ; the duration of oxygen treatment will also be recorded, Occurrence of a postoperative opioid-related ileus within the first 48 hours after extubation, Occurrence of a postoperative opioid-related absence of flatus or stools, Postoperative pain (numeric rating scale) after extubation at rest and during movement: every 10 minutes in PACU (Post-Anesthesia Care Unit) and every 6 hours until 48 hours after surgery, Opioid consumption (mg) during the 48 hours following extubation, Time between extubation (H0) and an Aldrete score ≥ 9, Rate of unscheduled admission in intensive care unit, Hospital length of stay (max 28 days) defined as the number of days after extubation (H0) before first hospital discharge, Pneumonia episodes | — |